VKH
CORV

Virtu KCG Holdings’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Virtu KCG Holdings’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,677
Closed -$47K – 3735
2017
Q1 		$47K Buy
+15,677
New +$46.2K ﹤0.01% 2855
2016
Q2 		– Sell
-10,001
Closed -$41K – 3491
2016
Q1 		$41K Buy
+10,001
New +$53.5K ﹤0.01% 2503
2014
Q1 		– Sell
-12,740
Closed -$79K – 4319
2013
Q4 		$79K Sell
12,740
-1,408
-10% -$7.38K ﹤0.01% 3504
2013
Q3 		$50K Buy
+14,148
New +$32.2K ﹤0.01% 3513

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.4M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return